Phase II trial of ciprofloxacin 0.3% otic foam (FoamOtic Externa) compared with ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension (Ciprodex) in patients aged 6 months and older with acute otitis externa.

Trial Profile

Phase II trial of ciprofloxacin 0.3% otic foam (FoamOtic Externa) compared with ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension (Ciprodex) in patients aged 6 months and older with acute otitis externa.

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jan 2015

At a glance

  • Drugs Ciprofloxacin (Primary) ; Ciprofloxacin/dexamethasone
  • Indications Otitis externa
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Jan 2015 New trial record
    • 07 Jan 2015 Results published in an Otic Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top